From: Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study
Characteristic
% (n/N) or median (IQR)
Female
46 % (43/93)
Participants from Manzini district
59 % (55/93)
Age (years)
27 [5–38]
Weight (kg)
58 [20–71]
Baseline haemoglobin concentration (g/dL)
11 [10–13]